Search filters

List of works by Antonia Martinetti

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: Endocrine and clinical results

scientific article published on 01 July 1997

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

scientific article published in January 2002

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

scientific article published on 26 August 2006

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

scientific article published in July 2002

Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer

scientific article published on 10 May 2016

Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?

scientific article published on 01 November 1997

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

scientific article published on 06 December 2006

Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens

scientific article

Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.

scientific article

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

scientific article

Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.

scientific article

Diagnostic and prognostic tumor markers in the gastrointestinal tract.

scientific article published in March 2001

Did Circulating Tumor Cells Tell us all they Could? The Missed Circulating Tumor Cell Message in Breast Cancer

scientific article published on 11 November 2015

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Ang

scientific article published on 01 February 1999

Effect of 10-day broccoli consumption on inflammatory status of young healthy smokers

scientific article

Effect of a Tomato Drink Intervention on Insulin-Like Growth Factor (IGF)-1 Serum Levels in Healthy Subjects

scientific article published on 01 January 2006

Effect of broccoli intake on markers related to oxidative stress and cancer risk in healthy smokers and nonsmokers

scientific article

Effect of two 4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer

scientific article published on 01 January 1994

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

scientific article

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

scientific article

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

scientific article published on 25 October 2016

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

scientific article published on 25 January 2017

Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study

scientific article published in November 2006

Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer

scientific article published on 11 April 2015

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

scientific article published in December 2004

Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer

scientific article published in October 2003

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

scientific article published on 18 May 2007

Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer

scientific article published on February 2011

Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma

scientific article published in January 2007

Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication

scientific article published on 19 October 2016

Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients

scientific article published in April 2002

Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues

scientific article published on 01 June 1995

The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels

scientific article published on 01 November 1997

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

scientific article

The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers

scientific article published on 01 December 2000

The minimal effective exemestane dose for endocrine activity in advanced breast cancer

scientific article published in April 1997

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

scientific article published on 01 August 2000

Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase

scientific article published on 21 April 2015

Urinary testosterone as a marker of risk of recurrence in operable breast cancer

scientific article published on 01 January 1993

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

scientific article published on 22 March 2016

c-erbB 2 Serum level as prognostic factor in hormonally treated advanced breast cancer patients

scientific article published on 01 August 2002